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Measuring Pacemaker Dose: 
A Clinical Perspective
Purpose
The number of patients presenting with pacemakers in our clinic has 
increased recently. Following AAPM recommendations, a treatment 
plan is developed that minimizes the dose to the pacemaker. The 
most efficient way to measure in vivo dose during treatment is to 
use MOSFETs or diodes which offer a simple but inaccurate (up to 
25% error) method of recording. In this abstract, we analyze the 
dose measured by these different devices in an attempt to assess 
pacemaker dose.
Method and Materials
Five patients with different disease sites and pacemakers were chosen. 
To simulate the treatment delivery, a Rando phantom was placed on 
the table in the patient treatment position. An ion chamber was taped 
to the phantom under 1 cm bolus. Two MOSFETs and a diode were 
placed on top of the bolus and the treatment was delivered. One cone 
beam CT was obtained where the pacemaker was in the field-of-view 
to quantify the MOSFET and diode reading in this situation.
Results
The measurement from the ion chamber agreed well with the 
predicted dose from the planning system. Some errors resulted from 
misalignment of the phantom and ion chamber. Both the MOSFET 
and diode measurements agreed with the ion chamber and TPS 
with greater distances. Dose from CBCT was overestimated for both 
MOSFETs and diodes.
Conclusion
The simplest and most efficient in vivo measurement is to use a 
MOSFET or diode. When the pacemaker is more than 20 cm from 
the field edge these dosimeters are appropriate. When the field is less 
than 20 cm away, the most accurate although inefficient method is to 
use an ion chamber since there is little angular or energy dependence 
unlike diodes or MOSFETs. Another solution would be to use TLDs 
or OSL dosimeters although these are not simplistic dosimeters either.
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